NYSE$NHI
National Health Investors Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
NHI's financial performance reflected stable cash collections and slightly better-than-expected deferral repayments.
National Health Investors, Inc. reported second quarter 2023 results with net income per diluted share of $0.92, NAREIT FFO per diluted share of $1.05, and Normalized FFO per diluted share of $1.06. The company revised its 2023 annual guidance for Normalized FFO per share to $4.31 - $4.35 and Normalized FAD to $185.0 million - $186.8 million.
- Net income attributable to common stockholders per diluted common share was $0.92, compared to $0.47 in the prior year.
- NAREIT FFO per diluted common share was $1.05, compared to $0.71 in the prior year.
- Normalized FFO per diluted common share was $1.06, compared to $1.27 in the prior year.
- The company sold six properties during the second quarter of 2023 for net proceeds of approximately $39.1 million.
Headline financials
Revenue & EPS history
NHI · Revenue · Quarterly
$77.9M
Revenue by segment
NHI · $68.4M total across 1 segment · Q2 2021
- Rental income$68.4M—100.0%
Forward guidance
NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42 and is revising Normalized FAD to a range of $185.0 million - $186.8 million from $186.3 million - $188.9 million.
Tailwinds
- Continued rent concessions
- Asset dispositions
- Loan repayments throughout 2023
- Approximately $60.6 million in investment funding for announced investments and fulfillment of existing commitments
- Includes continuing collection of deferred rents in line with quarterly year-to-date deferred rent collections excluding $2.5 million non-cash revenue recognition for the Bickford property acquisition in the first quarter of 2023
Headwinds
- Higher second quarter of 2023 rent concessions
- Incremental asset disposition
- Increased interest rates
- Increased range for the non-cash amortization of lease incentives
- No incremental benefit from unidentified acquisitions
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.1%
Avg return
Earnings day
+0.6%
Avg return
5 days after
+1.3%
Avg return
30 days after
59%
40 / 68 earnings
Positive
+14.9%
Q3 2020
Best reaction
-7.9%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.4% | -1.9% | -9.4% | |
| Q4 2025 | -4.2% | -3.2% | -6.3% | |
| Q3 2025 | +1.8% | +1.1% | +4.1% | |
| Q1 2025 | +0.5% | +1.0% | -6.2% | |
| Q4 2024 | -0.2% | +2.9% | +4.8% | |
| Q3 2024 | +1.1% | +7.0% | -0.4% | |
| Q2 2024 | +3.0% | +3.2% | +13.8% | |
| Q1 2024 | +1.4% | +0.9% | +2.8% | |
| Q4 2023 | +6.6% | +8.4% | +16.5% | |
| Q3 2023 | +0.5% | -0.7% | +7.8% | |
| Q2 2023 | -7.5% | -6.7% | -9.4% | |
| Q1 2023 | +7.6% | +8.3% | +8.0% | |
| Q4 2022 | -7.9% | -6.5% | -17.5% | |
| Q3 2022 | -1.4% | +3.4% | +2.1% | |
| Q2 2022 | +2.6% | +4.9% | +4.5% | |
| Q1 2022 | -3.4% | +1.4% | +12.8% | |
| Q4 2021 | -3.2% | -2.0% | +6.4% | |
| Q3 2021 | +1.4% | +1.8% | +1.4% | |
| Q2 2021 | -6.2% | -5.5% | -9.7% | |
| Q1 2021 | -3.1% | -4.9% | -5.6% | |
| Q4 2020 | -0.6% | +0.1% | +7.5% | |
| Q3 2020 | +14.9% | +18.0% | +20.7% | |
| Q2 2020 | +0.1% | -2.8% | -1.0% | |
| Q1 2020 | -4.2% | -11.3% | +19.2% | |
| Q4 2019 | +1.4% | +1.8% | -57.5% | |
| Q3 2019 | -2.0% | -2.0% | +1.0% | |
| Q2 2019 | +2.1% | +2.0% | +3.9% | |
| Q1 2019 | -1.2% | +0.8% | +3.4% | |
| Q4 2018 | -6.9% | -4.0% | -5.7% | |
| Q3 2018 | +1.6% | +2.4% | +8.0% | |
| Q2 2018 | +1.0% | +0.1% | +3.1% | |
| Q1 2018 | +1.9% | +1.7% | +6.7% | |
| Q4 2017 | +0.0% | +0.8% | +7.5% | |
| Q3 2017 | -2.9% | -1.5% | -0.6% | |
| Q2 2017 | +1.0% | +2.8% | +6.7% | |
| Q1 2017 | +2.5% | +4.4% | +5.1% | |
| Q4 2016 | +0.7% | +1.1% | -3.9% | |
| Q3 2016 | -0.3% | -5.5% | +1.1% | |
| Q2 2016 | +0.6% | +2.0% | +3.4% | |
| Q1 2016 | +1.9% | — | — | |
| Q4 2015 | +3.8% | — | — | |
| Q3 2015 | -0.1% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | +1.5% | — | — | |
| Q4 2014 | +0.4% | — | — | |
| Q3 2014 | -0.7% | — | — | |
| Q2 2014 | +2.6% | — | — | |
| Q1 2014 | +1.5% | — | — | |
| Q4 2013 | -1.0% | — | — | |
| Q3 2013 | -0.7% | — | — | |
| Q2 2013 | -0.0% | — | — | |
| Q1 2013 | +3.3% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | +1.3% | — | — | |
| Q2 2012 | -2.7% | — | — | |
| Q1 2012 | +1.2% | — | — | |
| Q4 2011 | -2.4% | — | — | |
| Q3 2011 | +0.8% | — | — | |
| Q2 2011 | -5.4% | — | — | |
| Q1 2010 | -2.5% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q4 2008 | +0.2% | — | — | |
| Q4 2010 | +0.2% | — | — | |
| Q3 2010 | +1.6% | — | — | |
| Q3 2009 | +1.6% | — | — | |
| Q2 2010 | +0.9% | — | — | |
| Q2 2009 | +0.9% | — | — | |
| Q4 2009 | +0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro